nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ABCB1—colon cancer	0.403	1	CbGaD
Alfentanil—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0572	0.109	CbGbCtD
Alfentanil—CYP3A7—Irinotecan—colon cancer	0.0572	0.109	CbGbCtD
Alfentanil—ALB—Irinotecan—colon cancer	0.0534	0.101	CbGbCtD
Alfentanil—ALB—Fluorouracil—colon cancer	0.0513	0.0974	CbGbCtD
Alfentanil—CYP3A7—Vincristine—colon cancer	0.05	0.095	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.05	0.095	CbGbCtD
Alfentanil—CYP3A5—Irinotecan—colon cancer	0.0429	0.0815	CbGbCtD
Alfentanil—CYP3A5—Vincristine—colon cancer	0.0375	0.0713	CbGbCtD
Alfentanil—ALB—Methotrexate—colon cancer	0.0283	0.0537	CbGbCtD
Alfentanil—ABCB1—Irinotecan—colon cancer	0.0279	0.0531	CbGbCtD
Alfentanil—ABCB1—Vincristine—colon cancer	0.0244	0.0464	CbGbCtD
Alfentanil—CYP3A4—Irinotecan—colon cancer	0.0167	0.0318	CbGbCtD
Alfentanil—ABCB1—Methotrexate—colon cancer	0.0148	0.0281	CbGbCtD
Alfentanil—CYP3A4—Vincristine—colon cancer	0.0146	0.0278	CbGbCtD
Alfentanil—ORM1—bile—colon cancer	0.00614	0.347	CbGeAlD
Alfentanil—ORM1—gall bladder—colon cancer	0.0017	0.0962	CbGeAlD
Alfentanil—Shivering—Capecitabine—colon cancer	0.00167	0.0314	CcSEcCtD
Alfentanil—Myoclonus—Vincristine—colon cancer	0.00159	0.0298	CcSEcCtD
Alfentanil—ALB—gall bladder—colon cancer	0.00149	0.0844	CbGeAlD
Alfentanil—Myoclonus—Capecitabine—colon cancer	0.00104	0.0194	CcSEcCtD
Alfentanil—Hiccups—Irinotecan—colon cancer	0.000932	0.0175	CcSEcCtD
Alfentanil—CYP3A7—liver—colon cancer	0.000789	0.0446	CbGeAlD
Alfentanil—Euphoric mood—Fluorouracil—colon cancer	0.000767	0.0144	CcSEcCtD
Alfentanil—Injection site pain—Capecitabine—colon cancer	0.000764	0.0143	CcSEcCtD
Alfentanil—Disorientation—Fluorouracil—colon cancer	0.000724	0.0136	CcSEcCtD
Alfentanil—Visual disturbance—Irinotecan—colon cancer	0.000714	0.0134	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Irinotecan—colon cancer	0.000699	0.0131	CcSEcCtD
Alfentanil—CYP3A7-CYP3A51P—liver—colon cancer	0.000671	0.0379	CbGeAlD
Alfentanil—Cardiac arrest—Vincristine—colon cancer	0.000661	0.0124	CcSEcCtD
Alfentanil—Cardiac arrest—Irinotecan—colon cancer	0.000643	0.0121	CcSEcCtD
Alfentanil—Blood pressure increased—Capecitabine—colon cancer	0.000624	0.0117	CcSEcCtD
Alfentanil—Hiccups—Capecitabine—colon cancer	0.000624	0.0117	CcSEcCtD
Alfentanil—ORM1—bone marrow—colon cancer	0.000618	0.0349	CbGeAlD
Alfentanil—Cardiac arrest—Fluorouracil—colon cancer	0.000616	0.0116	CcSEcCtD
Alfentanil—Apnoea—Methotrexate—colon cancer	0.000548	0.0103	CcSEcCtD
Alfentanil—ABCB1—blood vessel—colon cancer	0.000535	0.0302	CbGeAlD
Alfentanil—ORM1—liver—colon cancer	0.000499	0.0282	CbGeAlD
Alfentanil—Bradycardia—Irinotecan—colon cancer	0.000476	0.00893	CcSEcCtD
Alfentanil—Connective tissue disorder—Vincristine—colon cancer	0.000472	0.00885	CcSEcCtD
Alfentanil—Epistaxis—Fluorouracil—colon cancer	0.000471	0.00883	CcSEcCtD
Alfentanil—Connective tissue disorder—Irinotecan—colon cancer	0.00046	0.00862	CcSEcCtD
Alfentanil—CYP3A5—renal system—colon cancer	0.000455	0.0257	CbGeAlD
Alfentanil—Visual impairment—Irinotecan—colon cancer	0.000451	0.00846	CcSEcCtD
Alfentanil—Cardiac disorder—Vincristine—colon cancer	0.000446	0.00836	CcSEcCtD
Alfentanil—ALB—liver—colon cancer	0.000438	0.0247	CbGeAlD
Alfentanil—Angiopathy—Vincristine—colon cancer	0.000436	0.00817	CcSEcCtD
Alfentanil—Cardiac disorder—Irinotecan—colon cancer	0.000434	0.00814	CcSEcCtD
Alfentanil—Mediastinal disorder—Vincristine—colon cancer	0.000433	0.00812	CcSEcCtD
Alfentanil—Cardiac arrest—Capecitabine—colon cancer	0.000431	0.00807	CcSEcCtD
Alfentanil—Angiopathy—Irinotecan—colon cancer	0.000425	0.00796	CcSEcCtD
Alfentanil—Immune system disorder—Irinotecan—colon cancer	0.000423	0.00793	CcSEcCtD
Alfentanil—Mediastinal disorder—Irinotecan—colon cancer	0.000422	0.00791	CcSEcCtD
Alfentanil—Mental disorder—Vincristine—colon cancer	0.000421	0.00789	CcSEcCtD
Alfentanil—Chills—Irinotecan—colon cancer	0.00042	0.00787	CcSEcCtD
Alfentanil—Arrhythmia—Irinotecan—colon cancer	0.000418	0.00784	CcSEcCtD
Alfentanil—Arrhythmia—Fluorouracil—colon cancer	0.0004	0.00751	CcSEcCtD
Alfentanil—Erythema—Fluorouracil—colon cancer	0.00039	0.00732	CcSEcCtD
Alfentanil—Bronchospasm—Capecitabine—colon cancer	0.000385	0.00722	CcSEcCtD
Alfentanil—Agitation—Vincristine—colon cancer	0.000384	0.00721	CcSEcCtD
Alfentanil—ORM1—lymph node—colon cancer	0.000383	0.0216	CbGeAlD
Alfentanil—CYP3A5—digestive system—colon cancer	0.000373	0.0211	CbGeAlD
Alfentanil—Vision blurred—Fluorouracil—colon cancer	0.000368	0.00689	CcSEcCtD
Alfentanil—Convulsion—Vincristine—colon cancer	0.000362	0.0068	CcSEcCtD
Alfentanil—Hypertension—Vincristine—colon cancer	0.000361	0.00677	CcSEcCtD
Alfentanil—Loss of consciousness—Irinotecan—colon cancer	0.000358	0.00671	CcSEcCtD
Alfentanil—Visual disturbance—Methotrexate—colon cancer	0.000356	0.00667	CcSEcCtD
Alfentanil—Cough—Irinotecan—colon cancer	0.000356	0.00667	CcSEcCtD
Alfentanil—Hypertension—Irinotecan—colon cancer	0.000352	0.00659	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Methotrexate—colon cancer	0.000348	0.00653	CcSEcCtD
Alfentanil—Anaphylactic shock—Vincristine—colon cancer	0.000341	0.0064	CcSEcCtD
Alfentanil—CYP3A4—renal system—colon cancer	0.000341	0.0193	CbGeAlD
Alfentanil—Convulsion—Fluorouracil—colon cancer	0.000338	0.00634	CcSEcCtD
Alfentanil—ALB—lymph node—colon cancer	0.000336	0.019	CbGeAlD
Alfentanil—Confusional state—Irinotecan—colon cancer	0.000335	0.00629	CcSEcCtD
Alfentanil—Nervous system disorder—Vincristine—colon cancer	0.000335	0.00628	CcSEcCtD
Alfentanil—Anaphylactic shock—Irinotecan—colon cancer	0.000333	0.00623	CcSEcCtD
Alfentanil—Hyperhidrosis—Vincristine—colon cancer	0.00033	0.00619	CcSEcCtD
Alfentanil—CYP3A5—vagina—colon cancer	0.000329	0.0186	CbGeAlD
Alfentanil—Epistaxis—Capecitabine—colon cancer	0.000329	0.00617	CcSEcCtD
Alfentanil—Nervous system disorder—Irinotecan—colon cancer	0.000326	0.00611	CcSEcCtD
Alfentanil—Hyperhidrosis—Irinotecan—colon cancer	0.000321	0.00603	CcSEcCtD
Alfentanil—Confusional state—Fluorouracil—colon cancer	0.000321	0.00602	CcSEcCtD
Alfentanil—Hypotension—Vincristine—colon cancer	0.000319	0.00598	CcSEcCtD
Alfentanil—ABCB1—embryo—colon cancer	0.000319	0.018	CbGeAlD
Alfentanil—Bradycardia—Capecitabine—colon cancer	0.000319	0.00598	CcSEcCtD
Alfentanil—Anaphylactic shock—Fluorouracil—colon cancer	0.000318	0.00597	CcSEcCtD
Alfentanil—Nervous system disorder—Fluorouracil—colon cancer	0.000312	0.00585	CcSEcCtD
Alfentanil—Tachycardia—Fluorouracil—colon cancer	0.000311	0.00583	CcSEcCtD
Alfentanil—Hypotension—Irinotecan—colon cancer	0.000311	0.00582	CcSEcCtD
Alfentanil—Connective tissue disorder—Capecitabine—colon cancer	0.000308	0.00577	CcSEcCtD
Alfentanil—Visual impairment—Capecitabine—colon cancer	0.000302	0.00566	CcSEcCtD
Alfentanil—Hypotension—Fluorouracil—colon cancer	0.000298	0.00558	CcSEcCtD
Alfentanil—Somnolence—Irinotecan—colon cancer	0.000296	0.00554	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Vincristine—colon cancer	0.000295	0.00553	CcSEcCtD
Alfentanil—Fatigue—Vincristine—colon cancer	0.000294	0.00552	CcSEcCtD
Alfentanil—Eye disorder—Capecitabine—colon cancer	0.000293	0.00549	CcSEcCtD
Alfentanil—Pain—Vincristine—colon cancer	0.000292	0.00547	CcSEcCtD
Alfentanil—Cardiac disorder—Capecitabine—colon cancer	0.000291	0.00545	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Irinotecan—colon cancer	0.000287	0.00538	CcSEcCtD
Alfentanil—Fatigue—Irinotecan—colon cancer	0.000287	0.00537	CcSEcCtD
Alfentanil—Pain—Irinotecan—colon cancer	0.000284	0.00533	CcSEcCtD
Alfentanil—Angiopathy—Capecitabine—colon cancer	0.000284	0.00533	CcSEcCtD
Alfentanil—Somnolence—Fluorouracil—colon cancer	0.000283	0.00531	CcSEcCtD
Alfentanil—Immune system disorder—Capecitabine—colon cancer	0.000283	0.0053	CcSEcCtD
Alfentanil—Mediastinal disorder—Capecitabine—colon cancer	0.000282	0.00529	CcSEcCtD
Alfentanil—Chills—Capecitabine—colon cancer	0.000281	0.00527	CcSEcCtD
Alfentanil—Arrhythmia—Capecitabine—colon cancer	0.00028	0.00525	CcSEcCtD
Alfentanil—CYP3A4—digestive system—colon cancer	0.00028	0.0158	CbGeAlD
Alfentanil—CYP3A5—liver—colon cancer	0.000278	0.0157	CbGeAlD
Alfentanil—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000275	0.00515	CcSEcCtD
Alfentanil—Mental disorder—Capecitabine—colon cancer	0.000274	0.00514	CcSEcCtD
Alfentanil—Feeling abnormal—Irinotecan—colon cancer	0.000274	0.00514	CcSEcCtD
Alfentanil—Erythema—Capecitabine—colon cancer	0.000273	0.00511	CcSEcCtD
Alfentanil—Pain—Fluorouracil—colon cancer	0.000272	0.00511	CcSEcCtD
Alfentanil—Body temperature increased—Vincristine—colon cancer	0.00027	0.00506	CcSEcCtD
Alfentanil—Body temperature increased—Irinotecan—colon cancer	0.000263	0.00493	CcSEcCtD
Alfentanil—Feeling abnormal—Fluorouracil—colon cancer	0.000262	0.00492	CcSEcCtD
Alfentanil—ABCB1—epithelium—colon cancer	0.00026	0.0147	CbGeAlD
Alfentanil—Drowsiness—Methotrexate—colon cancer	0.00026	0.00487	CcSEcCtD
Alfentanil—Vision blurred—Capecitabine—colon cancer	0.000257	0.00482	CcSEcCtD
Alfentanil—Urticaria—Fluorouracil—colon cancer	0.000253	0.00474	CcSEcCtD
Alfentanil—Body temperature increased—Fluorouracil—colon cancer	0.000252	0.00472	CcSEcCtD
Alfentanil—Hypersensitivity—Vincristine—colon cancer	0.000252	0.00472	CcSEcCtD
Alfentanil—Epistaxis—Methotrexate—colon cancer	0.000245	0.00459	CcSEcCtD
Alfentanil—Hypersensitivity—Irinotecan—colon cancer	0.000245	0.00459	CcSEcCtD
Alfentanil—Asthenia—Vincristine—colon cancer	0.000245	0.00459	CcSEcCtD
Alfentanil—ABCB1—renal system—colon cancer	0.000241	0.0136	CbGeAlD
Alfentanil—Loss of consciousness—Capecitabine—colon cancer	0.00024	0.00449	CcSEcCtD
Alfentanil—Asthenia—Irinotecan—colon cancer	0.000239	0.00447	CcSEcCtD
Alfentanil—Cough—Capecitabine—colon cancer	0.000238	0.00446	CcSEcCtD
Alfentanil—Hypertension—Capecitabine—colon cancer	0.000235	0.00441	CcSEcCtD
Alfentanil—Hypersensitivity—Fluorouracil—colon cancer	0.000235	0.0044	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000231	0.00432	CcSEcCtD
Alfentanil—Dizziness—Vincristine—colon cancer	0.000226	0.00423	CcSEcCtD
Alfentanil—Pruritus—Fluorouracil—colon cancer	0.000225	0.00422	CcSEcCtD
Alfentanil—Visual impairment—Methotrexate—colon cancer	0.000225	0.00421	CcSEcCtD
Alfentanil—Confusional state—Capecitabine—colon cancer	0.000224	0.00421	CcSEcCtD
Alfentanil—Dizziness—Irinotecan—colon cancer	0.00022	0.00412	CcSEcCtD
Alfentanil—Nervous system disorder—Capecitabine—colon cancer	0.000218	0.00409	CcSEcCtD
Alfentanil—Eye disorder—Methotrexate—colon cancer	0.000218	0.00409	CcSEcCtD
Alfentanil—Tachycardia—Capecitabine—colon cancer	0.000217	0.00407	CcSEcCtD
Alfentanil—Vomiting—Vincristine—colon cancer	0.000217	0.00407	CcSEcCtD
Alfentanil—Cardiac disorder—Methotrexate—colon cancer	0.000216	0.00406	CcSEcCtD
Alfentanil—Skin disorder—Capecitabine—colon cancer	0.000216	0.00405	CcSEcCtD
Alfentanil—Rash—Vincristine—colon cancer	0.000215	0.00404	CcSEcCtD
Alfentanil—Hyperhidrosis—Capecitabine—colon cancer	0.000215	0.00403	CcSEcCtD
Alfentanil—Dermatitis—Vincristine—colon cancer	0.000215	0.00403	CcSEcCtD
Alfentanil—Headache—Vincristine—colon cancer	0.000214	0.00401	CcSEcCtD
Alfentanil—Angiopathy—Methotrexate—colon cancer	0.000212	0.00397	CcSEcCtD
Alfentanil—Vomiting—Irinotecan—colon cancer	0.000211	0.00396	CcSEcCtD
Alfentanil—Immune system disorder—Methotrexate—colon cancer	0.000211	0.00395	CcSEcCtD
Alfentanil—Dizziness—Fluorouracil—colon cancer	0.000211	0.00395	CcSEcCtD
Alfentanil—Mediastinal disorder—Methotrexate—colon cancer	0.00021	0.00394	CcSEcCtD
Alfentanil—Rash—Irinotecan—colon cancer	0.00021	0.00393	CcSEcCtD
Alfentanil—Dermatitis—Irinotecan—colon cancer	0.000209	0.00393	CcSEcCtD
Alfentanil—Chills—Methotrexate—colon cancer	0.000209	0.00392	CcSEcCtD
Alfentanil—CYP3A4—liver—colon cancer	0.000208	0.0118	CbGeAlD
Alfentanil—Headache—Irinotecan—colon cancer	0.000208	0.00391	CcSEcCtD
Alfentanil—Hypotension—Capecitabine—colon cancer	0.000208	0.0039	CcSEcCtD
Alfentanil—Mental disorder—Methotrexate—colon cancer	0.000204	0.00383	CcSEcCtD
Alfentanil—Erythema—Methotrexate—colon cancer	0.000203	0.00381	CcSEcCtD
Alfentanil—Nausea—Vincristine—colon cancer	0.000203	0.0038	CcSEcCtD
Alfentanil—Vomiting—Fluorouracil—colon cancer	0.000202	0.0038	CcSEcCtD
Alfentanil—Rash—Fluorouracil—colon cancer	0.000201	0.00376	CcSEcCtD
Alfentanil—Dermatitis—Fluorouracil—colon cancer	0.000201	0.00376	CcSEcCtD
Alfentanil—ABCB1—lymphoid tissue—colon cancer	0.0002	0.0113	CbGeAlD
Alfentanil—Headache—Fluorouracil—colon cancer	0.0002	0.00374	CcSEcCtD
Alfentanil—ABCB1—digestive system—colon cancer	0.000198	0.0112	CbGeAlD
Alfentanil—Nausea—Irinotecan—colon cancer	0.000198	0.0037	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Capecitabine—colon cancer	0.000192	0.0036	CcSEcCtD
Alfentanil—Fatigue—Capecitabine—colon cancer	0.000192	0.0036	CcSEcCtD
Alfentanil—Vision blurred—Methotrexate—colon cancer	0.000191	0.00359	CcSEcCtD
Alfentanil—Pain—Capecitabine—colon cancer	0.00019	0.00357	CcSEcCtD
Alfentanil—Nausea—Fluorouracil—colon cancer	0.000189	0.00355	CcSEcCtD
Alfentanil—Feeling abnormal—Capecitabine—colon cancer	0.000183	0.00344	CcSEcCtD
Alfentanil—ABCB1—bone marrow—colon cancer	0.000183	0.0103	CbGeAlD
Alfentanil—Cough—Methotrexate—colon cancer	0.000177	0.00332	CcSEcCtD
Alfentanil—Urticaria—Capecitabine—colon cancer	0.000177	0.00331	CcSEcCtD
Alfentanil—Body temperature increased—Capecitabine—colon cancer	0.000176	0.0033	CcSEcCtD
Alfentanil—Convulsion—Methotrexate—colon cancer	0.000176	0.0033	CcSEcCtD
Alfentanil—ABCB1—vagina—colon cancer	0.000175	0.00988	CbGeAlD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000172	0.00322	CcSEcCtD
Alfentanil—Confusional state—Methotrexate—colon cancer	0.000167	0.00313	CcSEcCtD
Alfentanil—Anaphylactic shock—Methotrexate—colon cancer	0.000166	0.00311	CcSEcCtD
Alfentanil—Hypersensitivity—Capecitabine—colon cancer	0.000164	0.00307	CcSEcCtD
Alfentanil—Nervous system disorder—Methotrexate—colon cancer	0.000162	0.00305	CcSEcCtD
Alfentanil—Skin disorder—Methotrexate—colon cancer	0.000161	0.00302	CcSEcCtD
Alfentanil—Hyperhidrosis—Methotrexate—colon cancer	0.00016	0.003	CcSEcCtD
Alfentanil—Asthenia—Capecitabine—colon cancer	0.00016	0.00299	CcSEcCtD
Alfentanil—Pruritus—Capecitabine—colon cancer	0.000157	0.00295	CcSEcCtD
Alfentanil—Hypotension—Methotrexate—colon cancer	0.000155	0.0029	CcSEcCtD
Alfentanil—ABCB1—liver—colon cancer	0.000148	0.00833	CbGeAlD
Alfentanil—Somnolence—Methotrexate—colon cancer	0.000147	0.00276	CcSEcCtD
Alfentanil—Dizziness—Capecitabine—colon cancer	0.000147	0.00276	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Methotrexate—colon cancer	0.000143	0.00268	CcSEcCtD
Alfentanil—Fatigue—Methotrexate—colon cancer	0.000143	0.00268	CcSEcCtD
Alfentanil—Pain—Methotrexate—colon cancer	0.000142	0.00266	CcSEcCtD
Alfentanil—Vomiting—Capecitabine—colon cancer	0.000141	0.00265	CcSEcCtD
Alfentanil—Rash—Capecitabine—colon cancer	0.00014	0.00263	CcSEcCtD
Alfentanil—Dermatitis—Capecitabine—colon cancer	0.00014	0.00263	CcSEcCtD
Alfentanil—Headache—Capecitabine—colon cancer	0.000139	0.00261	CcSEcCtD
Alfentanil—Feeling abnormal—Methotrexate—colon cancer	0.000137	0.00256	CcSEcCtD
Alfentanil—Nausea—Capecitabine—colon cancer	0.000132	0.00248	CcSEcCtD
Alfentanil—Urticaria—Methotrexate—colon cancer	0.000132	0.00247	CcSEcCtD
Alfentanil—Body temperature increased—Methotrexate—colon cancer	0.000131	0.00246	CcSEcCtD
Alfentanil—Hypersensitivity—Methotrexate—colon cancer	0.000122	0.00229	CcSEcCtD
Alfentanil—Asthenia—Methotrexate—colon cancer	0.000119	0.00223	CcSEcCtD
Alfentanil—Pruritus—Methotrexate—colon cancer	0.000117	0.0022	CcSEcCtD
Alfentanil—ABCB1—lymph node—colon cancer	0.000113	0.00639	CbGeAlD
Alfentanil—Dizziness—Methotrexate—colon cancer	0.00011	0.00205	CcSEcCtD
Alfentanil—Vomiting—Methotrexate—colon cancer	0.000105	0.00197	CcSEcCtD
Alfentanil—Rash—Methotrexate—colon cancer	0.000104	0.00196	CcSEcCtD
Alfentanil—Dermatitis—Methotrexate—colon cancer	0.000104	0.00196	CcSEcCtD
Alfentanil—Headache—Methotrexate—colon cancer	0.000104	0.00195	CcSEcCtD
Alfentanil—Nausea—Methotrexate—colon cancer	9.84e-05	0.00184	CcSEcCtD
